Jazz Pharmaceuticals plc Operating Leases, Future Minimum Payments, Due in Two Years
Jazz Pharmaceuticals plc (JAZZ) had Operating Leases, Future Minimum Payments, Due in Two Years of $6.27 million as of 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $6.27M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $8.17M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $15.81M.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $15.57M.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $6.27M 10-K · filed 2019-02-26 |
| 2017-12-31 | $8.17M 10-K · filed 2018-02-27 |
| 2017-09-30 | $15.81M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $15.57M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $12.24M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $12.26M 10-K · filed 2017-02-28 |
| 2016-09-30 | $15.46M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $13.44M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $13.01M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $12.71M 10-K · filed 2016-02-23 |
| 2015-09-30 | $11.68M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $11.43M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $7.61M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $7.85M 10-K · filed 2015-02-24 |
| 2014-09-30 | $9.99M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $10.02M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $9.89M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $9.13M 10-K · filed 2014-02-25 |
| 2013-09-30 | $9.50M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $8.71M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $5.83M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $6.10M 10-K · filed 2013-02-26 |
| 2012-09-30 | $6.80M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $6.67M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $4.18M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $1.17M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |